Browsing by Author Fay, Keith

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2015Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathySue, Carolyn; Accarino, Anna; Bakker, Jaap A.; Barba, Pere; Beguin, Yves; Boelens, Jaap; Casali, C; Chinnery, Patrick F; Collin, Matthew; de Coo, Irenaeus F. M.; Dotti, Maria T.; Elhasid, R; Fay, Keith; Ferra, Chrristelle; Filosto, Massimiliano; Gratwohl, A.; Halter, Jörg; Hammans, Simon; Hirano, M; Illa, Isabel; M Sue, C; Mandel, Hanna; Marotta, Giuseppe; Marti, Ramon; Nachbaur, David; Orchard, Kim; Pinto Simoes, Belinda; Pintos, Guillem; Rovelli, Attilio; Savage, David; Schupbach, W. Michael M.; Sobreira, Claudia; Valcarel, David; Zoller, Heinz; Northern Clinical School: MedicineAllogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy, Brain, vol.138, 10, 2015,pp 2847-2858
2017Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14Trotman, Judith; Butcher, Belinda; Cull, Gavin; et al, Various; Fay, Keith; Gandhi, Maher K.; Gill, Devinder; Hertzberg, Mark; Ho, Shir-Jing; Johnston, Amanda; Taper, John; Concord Clinical School: MedicineEarly treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14, Haematologica, vol.102, 2, 2017,pp 356-363
2003Extramedullary presentation of acute leukaemia: a case of myeloid/natural killer cell precursor leukaemiaWard, Christopher; Chen, Vivien M Y; Fay, Keith; Loui, Jenny P. Y.; McIlroy, Kirsten; Medicine Faculty OfficeExtramedullary presentation of acute leukaemia: a case of myeloid/natural killer cell precursor leukaemia, Pathology, vol.35,(4),2003,pp 325-329
2014Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: What are the risks?Buckland, Michael; Clarke, A C; Elijah, J; Fay, Keith; Grimpen, F; Joseph, J.; Moore, J; Pavli, P; Subramaniam, Kavitha; Talaulikar, D; Yeung, D; School of Medical Sciences: Brain & Mind Research InstituteHepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: What are the risks?, Internal Medicine Journal, vol.44, 3, 2014,pp 287-290
2017Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantationGreenwood, Matthew; Kerridge, Ian; Stevenson, William; Arthur, Christopher; Coyle, Luke; Fay, Keith; Lindsay, Julian; Sandaradura, Indy; Wong, Kelly; Northern Clinical School: Kolling Institute; School of Public Health: Ctr for Values Ethics & Law in Med; Northern Clinical School: MedicineSerum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation, Journal of Antimicrobial Chemotherapy, vol.72, 12, 2017,pp 3414-3419